| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/07/2007 | EP1748764A2 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 02/07/2007 | EP1748759A2 Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions |
| 02/07/2007 | EP1748758A1 Spot-on formulation useful for cosmetology and dermatology |
| 02/07/2007 | EP1748749A2 Systems and methods for treating panic attacks |
| 02/07/2007 | EP1653895B1 Condom with a coating and composition |
| 02/07/2007 | EP1542753B1 Pharmaceutical compositions |
| 02/07/2007 | EP1448656B1 Biodegradable polymer |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1126875B1 Dispensing device for a pharmaceutically active composition |
| 02/07/2007 | EP0946154A4 Liquisolid systems and methods of preparing same |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | EP0602112B1 High content ibuprofen agglomerates and process to prepare them |
| 02/07/2007 | CN1909930A Transglutaminase mediated conjugation of peptides |
| 02/07/2007 | CN1909929A Anti-inflammatory analgesic for external use |
| 02/07/2007 | CN1909900A Association of antimicrobial compounds with surfaces and polymers |
| 02/07/2007 | CN1909898A 滴眼剂组合物 The composition of eye drops |
| 02/07/2007 | CN1909893A Propofol-containing fat emulsion preparation |
| 02/07/2007 | CN1909887A Support accumulating in injured part in vascular channel |
| 02/07/2007 | CN1909886A Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 02/07/2007 | CN1908033A Crosslinking poly(organophosphazenes) microsphere and preparation method thereof |
| 02/07/2007 | CN1907494A Polybutylcyanoacrylate nano-granule with resolubity, its application and use thereof |
| 02/07/2007 | CN1907294A Compound recipe copper sulfate cold cream |
| 02/07/2007 | CN1907292A Emulsion of baicalin for injection and its preparation process |
| 02/07/2007 | CN1907289A Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds |
| 02/07/2007 | CN1907288A No dump-agglomeration powder phospholipid and preparation process thereof |
| 02/07/2007 | CN1907284A Pharmaceutical composition containing pemetrexed |
| 02/07/2007 | CN1907273A Production method of nicotine transdermal preparation |
| 02/07/2007 | CN1907269A Aminoglucose composite effervescent preparation |
| 02/07/2007 | CN1907266A Potassium dehydroandrographolide succinate/potassium dehydroandrographolide succinate liposome composition and production method thereof |
| 02/07/2007 | CN1907265A Self-micro-emulsifying composition comprising amphipathic polymer and process for its preparation |
| 02/07/2007 | CN1907264A Compound sulfonamide suspensoid and its preparing process |
| 02/07/2007 | CN1907261A Long-acting carbostyril family antibacterial drugs suspension injection |
| 02/07/2007 | CN1907260A Hydrocortisone clyster agent and method for preparing the same |
| 02/07/2007 | CN1907259A Starch oral colon-target aqueous gel and its preparation method and use |
| 02/07/2007 | CN1298398C Medicament-loaded transdermal reservoir and method for its formation |
| 02/07/2007 | CN1298387C Vaccine composition and stabilisation method |
| 02/07/2007 | CN1298330C Self-administered contraceptive injection of oily solution |
| 02/07/2007 | CN1298326C Transdermal patch for external use comprising fentanyl |
| 02/07/2007 | CN1298320C Esmolol formulation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298317C Tamsulosin tablets |
| 02/07/2007 | CN1298316C Pharma ceutical formulation containing LTB4 antagonist |
| 02/07/2007 | CN1298315C Coated tablets and process for producing the same |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/07/2007 | CN1298313C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 02/06/2007 | US7173154 Transfection reagents |
| 02/06/2007 | US7173116 Nucleic acid formulations for gene delivery and methods of use |
| 02/06/2007 | US7173113 Endothelial growth factor-follicle stimulating hormone compounds having increased serum half-lives relative to native hormones; for increasing fertility, egg production and spermatogenesis, and increasing vascularization in tissue |
| 02/06/2007 | US7173041 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7172999 Using carbohydrates or zwitterions |
| 02/06/2007 | US7172889 Orally administered; activated and conditioned yeast cells cultured in electromagnetic fields |
| 02/06/2007 | US7172888 Orally administered; activated and conditioned yeast cells; culturing yeast cells of Saccharomyces cerevisiae Hansen strain electromagnetic fields |
| 02/06/2007 | US7172770 Mesoporous compositions for use in drug delivery |
| 02/06/2007 | US7172768 Storage stable powder compositions of interleukin-4 receptor |
| 02/06/2007 | US7172766 Dry powder inhalation formulations which are capable of providing a slow, continuous release of drug while also being biodegradable or expellable from the pulmonary or nasal tract; bioavailability |
| 02/06/2007 | US7172764 Rescue agents for treating botulinum toxin intoxications |
| 02/06/2007 | US7172755 Process control; metastasis; polypeptides |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2207077C Cross-linked microparticles and their use as therapeutic vehicles |
| 02/06/2007 | CA2203367C Foamable formulation and foam |
| 02/02/2007 | WO2007019845A2 Method for encapsulating therapeutic substances in cells |
| 02/02/2007 | CA2619278A1 Method for encapsulating therapeutic substances in cells |
| 02/01/2007 | WO2007014352A2 Antiviral phosphonate conjugates for inhibition of hiv |
| 02/01/2007 | WO2007013794A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | WO2007013661A1 Percutaneously absorbable ophthalmic preparation |
| 02/01/2007 | WO2007013634A1 Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 02/01/2007 | WO2007013633A1 Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 02/01/2007 | WO2007013600A1 Neutron capture preparation and use thereof |
| 02/01/2007 | WO2007013591A1 Non-invasive drug delivery system targeting posterior eye tissue using gel composition |
| 02/01/2007 | WO2007013590A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 02/01/2007 | WO2007013490A1 Aqueous solution preparation containing camptothecins |
| 02/01/2007 | WO2007013480A2 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 02/01/2007 | WO2007013452A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 02/01/2007 | WO2007013409A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 02/01/2007 | WO2007013100A1 Gel formulation comprising platelet derived growth factor |
| 02/01/2007 | WO2007012974A2 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 02/01/2007 | WO2007012876A1 Hydrogel particle |
| 02/01/2007 | WO2007012857A1 Topical formulations containing sporopollenin |
| 02/01/2007 | WO2007012856A1 Uses of sporopollenin |
| 02/01/2007 | WO2007012838A2 Drug delivery system |
| 02/01/2007 | WO2007012837A2 Compositions for treating psychiatric conditions |
| 02/01/2007 | WO2007012625A1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 02/01/2007 | WO2007012191A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | WO2007012125A1 Modified inorganic materials |
| 02/01/2007 | WO2006122128A3 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 02/01/2007 | WO2006108405A3 Nanoparticle/active ingredient conjugate |
| 02/01/2007 | WO2006104852A3 Vegf antagonist formulations |
| 02/01/2007 | WO2006058278A3 Methods for improving liver clearance of xenobiotic substances in an animal |
| 02/01/2007 | WO2006045056A3 Flavonoid composition for treating oral diseases |
| 02/01/2007 | WO2006032441A3 Stoichiometrically defined dye-labeled substances for measuring glomerular filtration rate |
| 02/01/2007 | WO2006015016A3 Photodynamic therapy and compositions for treating ocular glaucoma |
| 02/01/2007 | WO2005117967A3 Anti-il-9 antibody formulations and uses thereof |
| 02/01/2007 | WO2005115105A3 Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase |
| 02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
| 02/01/2007 | WO2005072334A3 Photoresponsive hydrogels |
| 02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
| 02/01/2007 | US20070027218 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof |
| 02/01/2007 | US20070027195 Novel compositions comprising higher primary alcohols and nicottinic acid and process of preparation thereof |
| 02/01/2007 | US20070027136 Formulations of anthraquinone derivatives |